ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
+10.95%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$772M
AUM Growth
+$772M
(-17%)
Cap. Flow
-$164M
Cap. Flow
% of AUM
-21.17%
Top 10 Holdings %
Top 10 Hldgs %
40.06%
Holding
112
New
25
Increased
11
Reduced
32
Closed
26
Top Buys
| 1 |
Arista Networks
ANET
|
$17.6M |
| 2 |
GAP
The Gap, Inc.
GAP
|
$11.4M |
| 3 |
Tarsus Pharmaceuticals
TARS
|
$9.81M |
| 4 |
Martin Marietta Materials
MLM
|
$8.57M |
| 5 |
Golar LNG
GLNG
|
$8.4M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$76.5M |
| 2 |
Mercado Libre
MELI
|
$24.7M |
| 3 |
Enphase Energy
ENPH
|
$15.7M |
| 4 |
argenx
ARGX
|
$12.8M |
| 5 |
Meta Platforms (Facebook)
META
|
$12.4M |
Sector Composition
| 1 | Healthcare | 30.17% |
| 2 | Technology | 23.62% |
| 3 | Industrials | 13.94% |
| 4 | Consumer Discretionary | 12.62% |
| 5 | Communication Services | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Masimo
MASI
$7.59B
| $6.08M | 0.65% |
+36,800
| New | +$6.08M |
|
52
Trade Desk
TTD
$26.7B
| $6.03M | 0.64% |
+51,300
| New | +$6.03M |
|
53
Progyny
PGNY
$2.04B
| $5.73M | 0.61% |
+332,000
| New | +$5.73M |
|
54
Duolingo
DUOL
$13.6B
| $5.64M | 0.6% |
17,400
-100
| -0.6% | -$32.4K |
|
55
Kymera Therapeutics
KYMR
$2.95B
| $5.49M | 0.58% |
136,500
+39,500
| +41% | +$1.59M |
|
56
Chart Industries
GTLS
$8.96B
| $5.27M | 0.56% |
+27,600
| New | +$5.27M |
|
57
Lantheus
LNTH
$3.73B
| $5.11M | 0.54% |
57,100
-15,900
| -22% | -$1.42M |
|
58
Ferguson
FERG
$46.4B
| $5.09M | 0.54% |
29,300
| – | – |
|
59
Embraer
ERJ
$10.3B
| $5.01M | 0.53% |
+136,600
| New | +$5.01M |
|
60
Affirm
AFRM
$28.8B
| $4.95M | 0.53% |
+81,300
| New | +$4.95M |
|
61
CAVA Group
CAVA
$7.83B
| $4.75M | 0.5% |
42,100
-42,900
| -50% | -$4.84M |
|
62
First Solar
FSLR
$20.9B
| $4.42M | 0.47% |
25,100
+1,600
| +7% | +$282K |
|
63
EchoStar
SATS
$17.8B
| $4.34M | 0.46% |
+189,360
| New | +$4.34M |
|
64
HEICO Class A
HEI.A
$34.1B
| $4.34M | 0.46% |
+23,300
| New | +$4.34M |
|
65
Oscar Health
OSCR
$4.31B
| $4.33M | 0.46% |
322,300
-10,700
| -3% | -$144K |
|
66
Arm
ARM
$147B
| $3.47M | 0.37% |
28,100
+18,100
| +181% | +$2.23M |
|
67
Astera Labs
ALAB
$30.3B
| $3.22M | 0.34% |
+24,300
| New | +$3.22M |
|
68
Soleno Therapeutics
SLNO
$3.6B
| $3.18M | 0.34% |
+70,700
| New | +$3.18M |
|
69
Xenon Pharmaceuticals
XENE
$2.98B
| $2.85M | 0.3% |
72,600
-53,400
| -42% | -$2.09M |
|
70
Warby Parker
WRBY
$3.2B
| $2.5M | 0.27% |
+103,338
| New | +$2.5M |
|
71
Axsome Therapeutics
AXSM
$6.05B
| $1.86M | 0.2% |
22,000
-35,000
| -61% | -$2.96M |
|
|
ABVX
72
Abivax
ABVX
$6.12B
| $761K | 0.08% |
103,929
-9,702
| -9% | -$71K |
|
|
DRUG
73
Bright Minds Biosciences
DRUG
$276M
| $540K | 0.06% |
+15,000
| New | +$540K |
|
74
DexCom
DXCM
$29.5B
| – | – |
-87,000
| Closed | -$5.83M |
|
|
75
Enphase Energy
ENPH
$4.93B
| – | – |
-138,800
| Closed | -$15.7M |
|